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Abstract 18 
A method was developed for the confirmatory and quantitative analysis of 30 β-lactam 19 
antibiotic residues in bovine muscle. The method includes 12 penicillins (amoxicillin, 20 
ampicillin, cloxacillin, dicloxacillin, mecillinam, methicillin, nafcillin, oxacillin, penicillin G, 21 
penicillin V, piperacillin, ticarcillin), 12 cephalosporins (cefacetrile, cefadroxil, cephalexin, 22 
cefalonium, cefazolin, cefoperazone, cefotaxime, cefquinome, cefuroxime, desacetyl 23 
cephapirin, desfuroylceftiofur cysteine disulfide, desfuroylceftiofur dimer), five carbapenems 24 
(biapenem, doripenem, ertapenem, imipenem, meropenem) and faropenem. Samples were 25 
extracted using a simple solvent extraction with acetonitrile:water (80:20, v/v) and C18 26 
dispersive solid-phase extraction (d-SPE) clean-up, followed by ultra-high performance 27 
liquid chromatography coupled to tandem mass spectrometry (UHPLC-MS/MS) detection. 28 
Chromatography was performed on a reversed phase CSH C18 column, using a binary 29 
gradient separation comprising of 0.01% formic acid and 0.2 mM ammonium acetate in water 30 
(mobile phase A) and 0.01% formic acid in acetonitrile (mobile phase B). The mass 31 
spectrometer was operated in the positive electrospray ionisation mode (ESI(+)). Validation 32 
was performed following the 2002/657/EC guidelines. Trueness ranged between 69% and 33 
143% and precision ranged between 2.0% and 29.9% under within-laboratory reproducibility 34 
conditions. Absolute recoveries ranged from 40.3% to 89%. The developed method uses 35 
minimal sample preparation and 30 test samples can be analysed by a single analyst in a 36 
single day. To the best of our knowledge, this is the first method for carbapenems in foodstuff 37 
that does not require derivatisation. 38 
 39 
 40 
1. Introduction 41 
The β-lactams are key antibiotics used in both human and veterinary medicine [1]. All of 42 
these drugs have a common four-membered ring in their molecular structure (Fig. 1). The 43 
penicillins, cephalosporins and carbapenems represent the most important β-lactam drug 44 
groups. In the penicillin and cephalosporin structures, the four-membered ring is fused to a 45 
five-membered thiazolidine or a six-membered dihydrothiazine ring, respectively. The 46 
carbapenems are similar to the penicillins, with a sulphur atom replaced by a carbon atom. 47 
Faropenem, a carbapenem-related compound, is another important member of the β-lactam 48 
class [2]. 49 
 50 
The β-lactams act by inhibiting the enzymes (PBPs, Penicillin-Binding Proteins) involved in 51 
the biosynthesis of the peptidoglycan, a fundamental constituent of the bacterial cell wall [3]. 52 
This is particularly important for actively multiplying bacteria, in which the β-lactams can 53 
cause cell lysis. Penicillins are classified as broad- or narrow-spectrum antimicrobials, based 54 
on their activity, or according to their susceptibility to β-lactamases produced by bacteria [1]. 55 
Cephalosporins are less susceptible to the action of β-lactamases and can be categorised into 56 
different generations [4]. In particular, their activity against Gram-positive bacteria decreases 57 
between the first and third generations, while their effectiveness against Gram-negative 58 
bacteria increases. The fourth-generation cephalosporins are broad-spectrum antimicrobials 59 
that are active against both Gram-positive and Gram-negative organisms [1]. 60 
 61 
Penicillins and cephalosporins are often administered parenterally and orally to food-62 
producing animals to prevent or treat bacterial infections. An inappropriate use of antibiotics 63 
may lead to residues in food, which can cause health hazards, such as allergic reactions in 64 
sensitive individuals. In addition, concerns have been raised over the excessive usage of 65 
antibiotics, which is linked to the increase of antimicrobial resistance in livestock and the 66 
potential transfer of resistant bacteria and resistant genes to humans and human pathogens, 67 
respectively [3]. This is particularly important among the third- and fourth-generation 68 
cephalosporins, due to the reliance of these drugs in human medicine as broad-spectrum 69 
antibiotics [5, 6]. Consequently, Maximum Residue Limits (MRLs) are established for 70 
different species and target tissues [7] and accurate methods become essential to measure the 71 
presence of non-compliant antibiotic residues in food. 72 
 73 
The monitoring of β-lactams in food of animal origin is complicated because of the 74 
differences in authorisation in food producing species. There are nine penicillin and eight 75 
cephalosporin active ingredients listed under Commission Regulation (EU) 37/2010 [7]. 76 
Many of the penicillin drugs are licensed for use in multiple species. For example, 77 
amoxicillin, ampicillin, cloxacillin, dicloxacillin, oxacillin and penicillin G are allowed in the 78 
treatment of all food-producing species. The other penicillins are licensed more specifically, 79 
e.g. nafcillin (all ruminant species), penicillin V (poultry and swines) and mecillinam (cattle 80 
only). 81 
 82 
The usage of cephalosporin antibiotics in food production has attracted much attention in 83 
recent years with calls to restrict the applications of third- and fourth-generation drugs. The 84 
European Commission recommends that the use of a narrow-spectrum antimicrobial should 85 
always be the first choice unless prior susceptibility testing shows that this would be 86 
ineffective [8]. Consequently, third- and fourth-generation cephalosporins should only be 87 
administered systemically to animals when clinical conditions respond poorly to narrow 88 
spectrum antibiotics. Among the first-generation cephalosporins, cefacetrile, cephalexin, 89 
cefalonium and cephapirin are approved for the treatment of cattle, while cefazolin is 90 
approved for cattle, goats and swines. Cefoperazone and ceftiofur belong to the third 91 
generation and are allowed in the treatment of cattle and all mammalian food-producing 92 
species, respectively. Cefquinome, a fourth-generation cephalosporin, is approved for cattle, 93 
horses and swine [7]. The carbapenems are broad spectrum antibiotics, resistant to most β-94 
lactamases. These drugs are not registered for use in food-producing animals, but play a 95 
critically important role in human medicine [9]. As a consequence, analytical methodologies 96 
should be capable of detecting MRL breaches for licensed drugs and the presence of residues 97 
from unauthorised applications. 98 
 99 
Different screening approaches are available for detecting antibiotic residues in food samples 100 
(immunoassays, microbial inhibition assays, receptor assays). The main advantages of these 101 
tests are simplicity, low cost and short analysis time, with no need for laborious sample 102 
preparation. However, most of these methods cannot identify or quantify the antibiotic that is 103 
present. In addition, some of these tests can lead to false positive or false negative results 104 
[10]. Liquid chromatography coupled to mass spectrometric detection has become the 105 
preferred technique to quantify and confirm the presence of β-lactams in foodstuffs. Several 106 
LC-MS(/MS) methods have been reported for the analysis of β-lactams in food matrices, 107 
mostly for milk [11-14]. A number of methods have also been published for the analysis of β-108 
lactams in tissue, including kidney [15-25], liver [20, 21, 24] and muscle [19-21, 23, 25-40]. 109 
The majority of these methods include a few penicillins and cephalosporins, or apply to 110 
specific drugs. The most comprehensive method was reported by Berendsen et al. for 22 β-111 
lactams in poultry muscle, including penicillins, cephalosporins and carbapenems [2]. Becker 112 
et al. also developed a sensitive and specific method for 15 β-lactams in bovine milk, muscle 113 
and kidney [41]. However, in both cases, the sample preparation involves a laborious 114 
procedure with solid phase extraction (SPE) clean-up. 115 
 116 
The objective of this study was to advance this analytical area and develop a comprehensive 117 
UHPLC-MS/MS method for monitoring the presence of the major β-lactams in both domestic 118 
and imported foods. The method aims to cover the antibiotics permitted for use in food-119 
producing animals as listed under EU legislation [7], novel drugs that are considered as 120 
critically important antibiotics for human use only, and metabolites, such as desacetyl 121 
cephapirin (DAC), desfuroylceftiofur cysteine disulfide (DCCD) and desfuroylceftiofur 122 
dimer (DCD). A further objective of this study was to develop a fast and easy sample 123 
preparation procedure that will reduce sample analysis time and simplify method 124 
implementation in regulatory laboratories. 125 
 126 
 127 
2. Materials and Methods 128 
 129 
2.1. Chemicals, standards and consumables 130 
Ampicillin trihydrate, cloxacillin sodium salt monohydrate, dicloxacillin sodium salt hydrate, 131 
mecillinam, methicillin sodium salt, nafcillin sodium salt monohydrate, oxacillin sodium salt 132 
monohydrate, penicillin V potassium salt, cefalonium hydrate, cephapirin sodium, biapenem, 133 
doripenem monohydrate, meropenem trihydrate and faropenem sodium hydrate were 134 
purchased from Sigma-Aldrich (Dublin, Ireland). Amoxicillin trihydrate, penicillin G 135 
potassium salt, piperacillin, ticarcillin monosodium, cefadroxil hydrate, cefazolin sodium salt, 136 
cefoperazone sodium salt, cefotaxime sodium salt, cefquinome sulphate, cefuroxime sodium 137 
salt, cephalexin monohydrate and imipenem were purchased from LGC Standards 138 
(Teddington, Middlesex, UK). DCCD and DCD were a gift from Zoetis (Kalamazoo, MI, 139 
USA). Cefacetrile, DAC sodium salt, ertapenem disodium 90% and the 10 internal standards 140 
amoxicillin-D4, ampicillin-D5, benzyl penicillanate-D7 potassium salt (penicillin G-D7), 141 
nafcillin-D5 sodium salt, penicillin V-D5, cefadroxil-D4 (major), cefazolin-
13C2
15N sodium 142 
salt, cephalexin-D5 hydrate, DAC-D6 sodium salt (major) and DCCD-D3 were supplied by 143 
Toronto Research Chemicals (Toronto, ON, Canada). 144 
 145 
Ultra-pure water (18.2 MΩ cm-1) was generated in-house using a Millipore water purification 146 
system (Millipore, Cork, Ireland). Acetonitrile (MeCN), methanol (MeOH) and hexane (all 147 
UHPLC grade) were supplied by Romil Ltd (Cambridge, UK). Dimethyl sulfoxide (DMSO), 148 
formic acid (HCOOH) 98-100%, trifluoroacetic acid (TFA), ammonium formate and 149 
ammonium acetate were supplied by Sigma-Aldrich. Glacial acetic acid (CH3COOH) 100% 150 
was purchased from Merck (Darmstadt, Germany). Sorbents tested for d-SPE included NH2 151 
(Bondesil-NH2 bulk sorbent, Agilent Technologies), PSA (Supelclean
TM primary/secondary 152 
amine SPE bulk sorbent, Sigma-Aldrich), C8 ISOLUTE bulk sorbent (Biotage, Uppsala, 153 
Sweeden), C18 (Agilent Technologies Ltd, Cork, Ireland), Z-Sep, Z-Sep+ and Z-Sep/C18 154 
(SupelTM QuE, 15 mL tubes, Sigma-Aldrich). Anhydrous magnesium sulphate (MgSO4) and 155 
sodium chloride (NaCl) were sourced from Sigma–Aldrich and Applichem (Darmstadt, 156 
Germany), respectively, and used as part of the QuEChERS (Quick, Easy, Cheap, Effective, 157 
Rugged and Safe) approach. 158 
 159 
Polypropylene tubes (15 mL and 50 mL) were obtained from Sarstedt Ltd (Wexford, Ireland). 160 
Membrane filters (Captiva Econo Filter PTFE 13m 0.2 µm) were sourced from Agilent 161 
Technologies Ltd. A ME36S microbalance and an A200S digital electronic analytical 162 
balance, both from Sartorius (Dublin, Ireland), were used for standard preparation (weighing 163 
of standard material and required solvent, respectively). An Ultra-Turrax probe blender from 164 
IKA (Staufen, Germany), a MSE Mistral 3000i centrifuge from Davidson and Hardy (Dublin, 165 
Ireland) and a TurboVap LV evaporator from Biotage were used for sample preparation. 166 
 167 
2.2. Preparation of standard solutions 168 
Individual stock solutions of ampicillin, cloxacillin, dicloxacillin, mecillinam, methicillin, 169 
nafcillin, oxacillin, penicillin G, penicillin V, ticarcillin, cefadroxil, cephalexin, cephapirin, 170 
cefazolin, cefoperazone, cefotaxime, cefuroxime, biapenem, doripenem, ertapenem, 171 
imipenem, meropenem, faropenem and the internal standards ampicillin-D5, penicillin G-D7, 172 
penicillin V-D5, nafcillin-D5, cefadroxil-D4, cefazolin-
13C2
15N and cephalexin-D5 were 173 
prepared at a concentration of 1 mg mL-1 in H2O:MeCN (75:25, v/v). Stock solutions of 174 
piperacillin and cefalonium were prepared at a concentration of 1 mg mL-1 in H2O:MeCN 175 
(50:50, v/v). Amoxicillin, amoxicillin-D4, DCCD and DCCD-D3 were dissolved in 176 
H2O:MeCN (50:50, v/v) at a concentration of 0.5 mg mL
-1. Cefacetrile, cefquinome, DAC, 177 
DAC-D6 and DCD were prepared in DMSO at a concentration of 1 mg mL
-1. After 178 
preparation, the solutions were stored in 2.5 mL aliquots in 15 mL polypropylene tubes at -179 
80°C. Under these storage conditions, individual stock solutions were found to be stable for 180 
at least two months. Three intermediate standard solutions containing all the β-lactams at 181 
concentrations ranging from 4 µg mL-1 to 200 µg mL-1 were prepared in water. Working 182 
calibration solutions were prepared by diluting the intermediate stock solutions in water. A 183 
mixed internal standard solution was prepared at concentrations ranging from 0.2 µg mL-1 to 184 
10 µg mL-1 in water. Working solutions were found to be stable for at least one month when 185 
stored at -80°C. 186 
 187 
2.3. Sample preparation 188 
Bovine muscle homogenate samples not containing any detectable β-lactam residues were 189 
used as negative controls. Sample aliquots (2 g ± 0.01 g) were weighed into a 50 mL 190 
polypropylene centrifuge tube. Extracted matrix calibrants were fortified with 100 µL of the 191 
working standard solutions. A 100 µL volume of internal standard solution was added to all 192 
calibrants, controls and test samples, which were then allowed to stand for 15 min. Water (1.9 193 
mL for the extracted matrix calibrants and 2 mL for the controls and test samples) and MeCN 194 
(8 mL) were added in order to extract the analytes from the matrix, and the polypropylene 195 
tubes containing the samples were subsequently homogenised for 20 s over ice using an 196 
Ultra-Turrax probe blender. The homogenised samples were centrifuged for 15 min at 197 
2842×g (4°C) and the supernatant was decanted into a 50 mL polypropylene tube containing 198 
500 mg of C18 sorbent. The samples were vortexed (40 s) and centrifuged for 15 min at 199 
2842×g (4°C). A 5 mL aliquot of the supernatant was placed into a 15 mL polypropylene 200 
tube and evaporated under nitrogen on a TurboVap at 40°C to a final aqueous volume of < 1 201 
mL. Solvent evaporation conditions required careful control to avoid degradation or loss of 202 
analytes. An evaporation temperature of 40°C was found to be optimal, while nitrogen gas 203 
pressure was dynamically controlled during the 55 min evaporation process. To avoid loss of 204 
sample, the nitrogen gas was maintained at 15 psi for the first 20 min. Subsequently, the 205 
pressure was gradually increased to 20 psi over 10 min, and the solvent evaporation time was 206 
greatly reduced by adapting this approach. After the evaporation, the volume was made up to 207 
1 mL with water and the extracts were vortexed for 10 s prior to filtration through 0.2 µm 208 
PTFE syringe filters. The filtered extracts were collected directly into autosampler vials and a 209 
10 µL volume was injected into the UHPLC-MS/MS system. 210 
 211 
2.4. Instruments and UHPLC-MS/MS conditions 212 
Samples were analysed using a Waters Acquity UHPLC system coupled to a Waters Quattro 213 
Premier triple quadrupole mass spectrometer (Milford MA, USA) equipped with ESI 214 
ionisation probe. The UHPLC-MS/MS system was controlled by MassLynx software (V4.1) 215 
and the results were processed by TargetLynx software (V4.1). Separation was performed on 216 
a stainless steel CSH C18 analytical column (2.1 × 100 mm, particle size 1.7 µm) fitted with 217 
an in-line filter with a 0.2 µm pore size. The column was maintained at 30°C, as higher 218 
temperatures were found to negatively affect the precision of the method. A binary gradient 219 
separation comprising of 0.01% HCOOH and 0.2 mM ammonium acetate in H2O (mobile 220 
phase A) and 0.01% HCOOH in MeCN (mobile phase B) was employed at a flow rate of 0.4 221 
mL min-1. The injection volume was 10 µL in full loop mode (overfill factor = 4). The 222 
gradient profile was as follows: (1) 0 - 1.5 min, 100% A; (2) 1.5 - 3.5 min, 80% A; (3) 3.5 - 223 
8.5 min, 20% A; (4) 8.5 - 8.6 min, 0% A; (5) 8.6 - 10.5 min, 0% A; (6) 10.5 - 10.6 min, 100% 224 
A, which was held for 7.4 min (re-equilibration of the column), for a total run time of 18 min. 225 
The UHPLC autosampler was rinsed after each injection using strong (H2O:MeCN, 20:80 226 
v/v, 750 µL) and weak (0.01% HCOOH in H2O:MeCN, 90:10 v/v, 1000 µL) washes. Sample 227 
temperature was maintained at 7°C in the autosampler. A divert valve was used to reduce 228 
source contamination (solvent delay: [a] 0 - 1.97 min; [b] 7.60 - 18 min). The mass 229 
spectrometer was operated in positive electrospray ionisation mode (ESI(+)) and the capillary 230 
voltage was set at 2.4 kV. Source and desolvation temperatures were 140°C and 450°C, 231 
respectively. Nitrogen was used as desolvation and cone gases and set at 1000 L h-1 and 100 232 
L h-1, respectively. Argon collision gas flow rate was set at 0.22 mL min-1. The MS tuning 233 
was performed by teed infusion of 1 µg mL-1 standards/internal standards with mobile phase 234 
A:B (50:50, v/v). The cone voltage and collision energy were optimised for each analyte and 235 
two product ions were selected so that a minimum of four identification points were obtained 236 
for all the analytes as required by Commission Decision 2002/657/EC [42]. A multiple-237 
reaction monitoring (MRM) method was developed with 15 different time-sectored events 238 
(Table 1). Inter-scan delay and inter-channel delay were set to 0.005 s. 239 
 240 
2.5. Validation 241 
The validation was performed following the 2002/657/EC guidelines [42]. The following 242 
parameters were assessed: identification, selectivity, linearity, trueness, within-laboratory 243 
repeatability (WLr), within-laboratory reproducibility (WLR), absolute recovery, decision 244 
limit (CCα) and detection capability (CCβ). Matrix effects, limit of detection (LOD) and limit 245 
of quantitation (LOQ) were also evaluated as part of the validation process. 246 
 247 
Identification was assessed by examining retention times, ion ratios and identification points. 248 
The selectivity of the method was investigated through injecting standard solutions of all 249 
analytes and internal standards individually and through testing 27 bovine muscles from 250 
different animals, in order to check the presence of any interferences eluted at the retention 251 
times of the analytes. The linearity of the curves was considered satisfactory if R2 ≥ 0.98 and 252 
if individual residuals did not deviate by more than ± 20% from the calibration curve. For the 253 
MRL-substances, trueness, WLr and WLR were assessed at 0.5, 1 and 1.5 times the MRLs 254 
established by current legislation [7], except for DCD and DCCD, which were validated at 255 
250, 500 and 750 µg kg-1. The non-MRL substances were validated around a target level (TL) 256 
that was identified based on the sensitivity of the method (Table 4). The WLr and WLR 257 
studies were both performed on three separate days by three different analysts. To evaluate 258 
WLr, a different bovine muscle negative control was used on each day, and eight portions of 259 
the sample were fortified at each validation level. To evaluate WLR, 21 different bovine 260 
muscle samples were used and seven bovine muscles, plus a mixture of them all, were 261 
fortified at each validation level. The available labelled compounds were used in the 262 
quantification of their corresponding analytes. Additionally, cloxacillin, dicloxacillin and 263 
oxacillin were all corrected using nafcillin-D5; cefacetrile, cefotaxime, cefuroxime and 264 
faropenem were corrected using cefazolin-13C2
15N; mecillinam and ertapenem using 265 
ampicillin-D5; cefalonium was corrected using cephalexin-D5 and doripenem using DAC-D6. 266 
No internal standards were used for the other analytes, as the available labelled compounds 267 
were found to be unsuitable in their quantification. Absolute recoveries were calculated by 268 
comparing results from fortified samples to those of negative samples spiked post-extraction 269 
at 2 × lowest calibration level and 0.875 × highest calibration level on three different 270 
occasions. For the MRL-substances, CCα and CCβ were calculated from the within-271 
laboratory reproducibility as defined in 2002/657/EC [42]. For the non-MRL substances, the 272 
same approach was used considering the TL, in order to obtain clearly detectable CCα and 273 
CCβ values in the range of the calibration curves. 274 
 275 
Matrix effects were also evaluated: 27 blank samples were spiked post-extraction at the 276 
MRLs or TLs and the signal obtained from those samples was compared to the signal 277 
obtained from a standard solution at the same concentration [43]. LODs and LOQs of all 278 
analytes were estimated from the blank samples fortified at the lowest calibration level on 279 
three different occasions, and measuring the signal-to-noise ratios at 3 and 10, respectively, 280 
for both quantifier and qualifier ions. 281 
 282 
 283 
3. Results and Discussion 284 
 285 
3.1. Method development 286 
 287 
3.1.1. UHPLC-MS/MS conditions 288 
The MS tuning experiments performed showed protonated molecules [M+H]+ for most of the 289 
β-lactams. The monitored precursor ion for DCD was [M+2H]2+; faropenem formed the 290 
sodium adduct [M+Na]+, while cefacetrile and cefuroxime surprisingly formed the 291 
ammonium adduct [M+NH4]
+. For the penicillins and cephalosporins, the product ions 292 
selected following low energy collision induced dissociation (CID) experiments generally 293 
matched those reported in the literature or characterized by Geis-Asteggiante et al. using 294 
electrospray ionization and quadrupole time-of-flight mass spectrometry (ESI-Q-TOF-MS) 295 
[44]. For the carbapenems, the monitored transitions were in agreement with those reported 296 
in the published LC-MS/MS methods for the determination of these drugs in urine, serum and 297 
other biological samples [45-48]. In order to get optimal sensitivity, the following MS 298 
parameters were optimised: capillary voltage, cone voltage, collision energy, source 299 
temperature and desolvation temperature. The response for mecillinam and nafcillin was very 300 
intense, consequently the MS was detuned to avoid saturation of the signal at high 301 
concentrations. 302 
 303 
The following additives were evaluated at different concentrations in both mobile phases A 304 
and B: 0.005%, 0.01% and 0.1% HCOOH; 0.01% and 0.1% CH3COOH; 0.001% and 0.1% 305 
TFA. The addition of ammonium acetate and ammonium formate in mobile phase A only 306 
was also investigated at concentrations ranging from 0.1 to 0.5 mM. Also, three different 307 
UHPLC column chemistries were assessed, namely, BEH C18, CSH C18 and HSS T3. 308 
Optimal results were achieved when using a binary gradient separation with a mobile phase 309 
containing (A) 0.01% HCOOH and 0.2 mM ammonium acetate in H2O and (B) 0.01% 310 
HCOOH in MeCN, on a CSH C18 column. A concentration of 0.01% HCOOH provided the 311 
best overall response, while higher concentrations of the same acid or use of different acids 312 
decreased sensitivity. Moreover, the removal of TFA from the UHPLC system after its use 313 
was found to be very difficult, and its presence seemed to affect other assays performed on 314 
the same instrument. The response for all analytes was also decreased when using higher 315 
concentrations of salts, consequently 0.2 mM ammonium acetate was added to mobile phase 316 
A to promote the formation of the ammonium adduct for two cephalosporins, namely 317 
cefacetrile and cefuroxime. The results obtained were in agreement with what reported in the 318 
literature. Formic acid is, indeed, the most common acidic agent used in the analysis of β-319 
lactams [11-13]. In addition, Becker et al. evaluated the effect of different concentrations of  320 
HCOOH and observed that the optimal chromatographic separation and ionisation efficiency 321 
were obtained with small amounts of acid in the eluent [41]. 322 
 323 
Different column temperatures were also tested (30°C, 40°C and 50°C) and the lower 324 
temperature was chosen, as it was shown to improve the precision of the method. The 325 
analytes particularly affected by the column temperature were imipenem, faropenem, 326 
cefuroxime, DCCD and DCD. A series of 25 injections of a 50 ng mL-1 mixed standard 327 
solution showed that the relative standard deviation (RSD%) for these compounds ranged 328 
from 6.3% (cefuroxime) to 11.5% (imipenem) when the column temperature was set at 50°C, 329 
while the precision improved at 30°C, with RSDs% ranging from 1.4% (faropenem) to 4.0% 330 
(DCD). The autosampler temperature was set at 7°C to prevent a potential degradation of the 331 
analytes. During each run performed in the proposed study, a matrix sample fortified at the 332 
MRLs/TLs was injected as check sample at evenly spaced intervals throughout the run to 333 
monitor the stability of the analytes in the autosampler. All the compounds were found to be 334 
stable for at least 24 hours at 7°C, as the absolute area obtained from the check sample stayed 335 
constant until the end of the run and the RSD% was not greater than 7.9%, except for 336 
imipenem (RSD% = 10.2%), for which the peak area decreased gradually, due to the 337 
instability of this compound. 338 
 339 
Gradient conditions and flow rate were adjusted in order to reach optimal chromatographic 340 
separation. The multiple reaction monitoring chromatograms in Fig. 2 show that all the 30 β-341 
lactams and the 10 internal standards were separated within the first 8 min of the 342 
chromatographic run. However, after 8.6 min, the gradient profile was held at 100% B for 343 
approximately 2 min, in order to remove the most non-polar matrix components from the 344 
column. Subsequently, a 7.4-min hold at 100% A was necessary for column equilibration, 345 
resulting in a total cycle time of 18 min. 346 
 347 
3.1.2. Sample preparation 348 
One of the main objectives of this study was to develop a rapid and easy sample preparation 349 
procedure. The QuEChERS method is well known for being a streamlined approach and was 350 
evaluated during preliminary studies, but gave unacceptably low recovery of polar analytes, 351 
likely due to partitioning into the aqueous layer. In contrast, a suitable protocol was identified 352 
based on the methods developed by Fagerquist et al. [17] and Mastovska and Lightfield [22]. 353 
They found that an extraction solvent composed of MeCN:H2O (80:20, v/v) was optimal for 354 
the isolation of 11 β-lactams from 1 g of bovine kidney. The sample weight was subsequently 355 
increased to 2 g by Schneider et al. [49] and the extraction procedure was applied to bovine 356 
kidney for the analysis of 120 veterinary drugs from different classes, including seven 357 
penicillins and eight cephalosporins. Geis-Asteggiante et al. [50] also adapted the same 358 
sample preparation to 2 g of bovine muscle for monitoring >100 veterinary drug residues, 359 
with the inclusion of seven penicillins and three cephalosporins. In our method, the volume of 360 
the extraction solvent was kept at 10 mL and the procedure used for the selective and 361 
efficient isolation of 12 penicillins, 12 cephalosporins, five carbapenems and faropenem from 362 
2 g of bovine muscle samples. 363 
 364 
With the exception of cefazolin, cefotaxime and faropenem, for which no significant 365 
difference was observed, all the analytes seemed to be affected by the sample temperature, 366 
which needed to be carefully controlled along the sample preparation process to prevent 367 
degradation of the β-lactam residues. During the method development, it was found that, after 368 
the addition of the extraction solvent, samples required homogenisation over ice, and that the 369 
maximum solvent evaporation temperature had to be restricted to 40°C. 370 
 371 
A number of sorbent materials were investigated for d-SPE: NH2 (500 mg), PSA (500 mg), 372 
C18 (500 mg), C8 (500 mg) and zirconium dioxide-based sorbents (Z-Sep (500 mg); Z-Sep+ 373 
(500 mg); Z-Sep/C18 (120 mg/ 300 mg)). NH2 and PSA are sorbents effective at retaining 374 
fatty acids and other organic acids present in food. C18 is often used for removing lipophilic 375 
compounds in food of animal origin, which has high lipid content. C8 is a sorbent generally 376 
employed for the extraction of non-polar compounds from matrices with low-fat content. Z-377 
Sep is a novel bonded silica sorbent that has been developed for the selective isolation of 378 
hydrophobic analytes from fatty matrices, while Z-sep/C18 or Z-sep+ are recommended for 379 
samples containing <15% fat and >15% fat, respectively. A liquid-liquid partitioning clean-380 
up was also tested using 6 mL of hexane, as an alternative to the d-SPE clean-up step. Geis-381 
Asteggiante et al. [50] reported a similar study for several veterinary drugs in bovine muscle, 382 
including 11 β-lactams. In their work, they evaluated the efficiency of different d-SPE 383 
sorbents (C18, Z-Sep, Z-Sep+) and/or partitioning with hexane in removing matrix co-384 
extracting by gravimetric measurements. The liquid-liquid partitioning with hexane was 385 
found to be the least efficient, followed by C18 clean-up. A combination of Z-Sep and C18 386 
resulted in the highest matrix removal, followed by Z-Sep + C18 + hexane and Z-Sep alone. 387 
However, further investigation on matrix effects and recoveries discouraged the use of these 388 
clean-up strategies; consequently, a combination of C18 and hexane was used in their sample 389 
preparation. In the proposed study, sensitivity, absolute recoveries and precision were 390 
evaluated for each of the clean-up approaches tested. NH2 and PSA sorbents were 391 
immediately discarded, as they provided unacceptable results for the majority of the analytes. 392 
Mastovska and Lightfield (2008) also found PSA to be unsuitable for the analysis of β-393 
lactams in bovine kidney, finding these drugs were retained by PSA, likely due to the 394 
carboxylic group present in the molecular structure [22]. Hexane provided high recoveries for 395 
cloxacillin, nafcillin and oxacillin, while the recoveries were not satisfactory for cefuroxime 396 
and DAC when using C8 sorbent. Among the zirconium dioxide-based sorbents, Z-Sep 397 
showed the lowest overall recoveries (particularly for the carbapenems) (Fig. 3). This result 398 
was in good agreement with that reported by Geis-Asteggiante et al. [50]. In their study, they 399 
found that the β-lactams were strongly retained when using a combination of Z-Sep and 400 
hexane. This could be due to the fact that zirconium can easily react with the carboxyl and 401 
hydroxyl groups present in the β-lactam structures and form strong bonds. In the proposed 402 
work, C18, Z-Sep+ and Z-Sep/C18 were found to be the most efficient strategies for all the 403 
substances, except for imipenem, which was found to be retained also by Z-Sep+ and Z-404 
Sep/C18 (Fig. 4). In addition, more precise results were obtained for the majority of 405 
compounds when using the C18 sorbent. As a consequence, C18 was chosen for the proposed 406 
sample preparation. 407 
 408 
3.2. Standard stability 409 
The stability issues associated with penicillin methanolic stock solutions were discovered 410 
when tuning was performed. The standards were initially dissolved in MeOH or H2O/MeOH 411 
and stored at -30°C. The MS tuning of 1 µg mL-1 standard aqueous solutions was originally 412 
performed immediately after standard preparation and subsequently repeated two weeks later. 413 
Interestingly, the MS spectra obtained from the second experiment for cloxacillin, 414 
dicloxacillin and penicillin V showed a mass corresponding to their methyl ester 415 
[M+CH3OH+H]
+. This was likely due to a breakdown of the β-lactam ring and the formation 416 
of a methanolic degradation product. The results raised curiosity, mostly because MeOH is a 417 
common solvent used in the analysis of β-lactams. In addition, contradictory information had 418 
been found in the literature regarding the stability of penicillin standards in solvent [17, 22, 419 
41, 51-53]. It was decided, then, to investigate the phenomenon for one of the problematic 420 
analytes, i.e. cloxacillin. The MS tuning was repeated after preparation of 1 mg mL-1 stock 421 
solutions in MeOH and H2O:MeCN (75:25, v/v), which were stored for 11 days in 1 mL 422 
aliquots under different storage conditions (room temperature, +4°C, -30°C and -80°C). The 423 
spectra obtained from the stock solutions in MeOH showed a mass at 436.0 m/z ([M+H]+), 424 
but also a mass at 468.0 m/z ([M+CH3OH+H]
+) that did not appear in the spectra obtained 425 
from the standard dissolved in H2O:MeCN (Fig. 5). All the different aliquots were 426 
subsequently diluted in water at a concentration of 10 µg mL-1. A MS scan was acquired 427 
following column injections and the chromatograms extracted for the ions 436.0 and 468.0 428 
m/z. As shown in Fig. 6, the signal obtained from 436.0 m/z was of lower intensity for the 429 
standard prepared in MeOH compared to the one prepared in H2O:MeCN, indicating some 430 
degradation for cloxacillin. The degradation in aliquots that had been stored at lower 431 
temperature was less (22% degradation at -80ºC and 19% at -30ºC) than the aliquots stored at 432 
+4ºC (81% degradation) or room temperature (99% degradation). However, a fresh solution 433 
prepared in MeOH also showed a mass at 468.0 m/z and 31% degradation for 436.0 m/z, 434 
which was surprisingly higher than what observed after storage at -80ºC and -30ºC. This was 435 
likely due to the fact that the fresh solution had been left at room temperature for 436 
approximately three hours before the dilution in water and the column injection. It can be 437 
concluded that the degradation of cloxacillin starts as soon as the standard is dissolved in 438 
MeOH and seems to be faster at higher storage temperatures. It should be noted that no 439 
significant difference was observed between the aliquots stored at +4°C and room 440 
temperature, but this was likely due to the saturation of the detector after the injection of high 441 
concentration standard solutions. 442 
 443 
The results obtained from the experiment were in good agreement with what was reported by 444 
Tyczkowska et al. [53] and Pellicciotti et al. [54]. Although no degradation appeared to be 445 
observed for the carbapenems and the cephalosporins, MeOH was completely removed from 446 
the standard preparation procedure, in order to avoid the presence of this solvent in the mixed 447 
standard solutions. As a consequence, alternative solvents (H2O:MeCN or DMSO) were 448 
selected. In addition, the standard solutions were stored in small aliquots (2.5 mL) at -80°C. 449 
 450 
3.3. Method validation 451 
 452 
3.3.1. Identification and confirmatory criteria 453 
In order to satisfy the confirmatory criteria outlined in 2002/657/EC, three identification 454 
points (one point for the precursor ion and 1.5 points for each product ion) are required to 455 
identify a group B substance. This criteria was exceeded in the proposed method, with four 456 
identification points obtained for each analyte. All the retention times and ion ratios measured 457 
during the validation study were within the maximum permitted tolerances [42], showing the 458 
suitability of the method in the identification and confirmation of 30 β-lactams in bovine 459 
muscle samples. 460 
 461 
3.3.2. Selectivity, linearity, LODs and LOQs 462 
Analytes and internal standards were injected individually in order to monitor for 463 
interferences in the UHPLC-MS/MS traces. The effects of cross-talk and isobaric 464 
interferences were minimised by identifying unique product ions for each compound and 465 
optimising the chromatographic separation, respectively. During the selectivity study, no 466 
matrix interferent peaks were observed for the majority of the analytes. An interference was 467 
observed for cefazolin, cefadroxil and cefadroxil-D4 product ions at 323.1, 114.1 and 213.1 468 
m/z, respectively. As a consequence, alternative product ions of lower intensity were selected. 469 
An interference was also observed for doripenem and cefalonium at 274.2 and 337.0 m/z, 470 
respectively. In the case of cefalonium, only two product ions (152.0 and 337.0 m/z) were 471 
generated in low energy CID experiments. In contrast, doripenem gave two additional 472 
product ions (112.1 and 318.1 m/z) to those selected (342.2 and 274.2 m/z), but the choice of 473 
these ions would have significantly decreased the sensitivity of the method. In addition, the 474 
quantifier and the qualifier ions for both analytes were of similar intensity; consequently it 475 
could be concluded that the observed peak was a real matrix interference (and not the actual 476 
analyte coming from a drug treatment of the animals), as no peaks were observed for the 477 
second ion. It is highlighted that the absolute area count obtained for the interferences was 478 
found to be negligible in all the tested blank samples, however further investigation would be 479 
needed for doripenem and cefalonium by analysing a larger number of bovine muscle 480 
samples. 481 
 482 
Linearity was achieved over the calibration range of the method. R2 was ≥ 0.988 for all the 483 
analytes, while individual residuals were in the ± 20% range from the calibration curve. 484 
LODs ranged between 0.010 μg kg-1 and 4.8 μg kg-1; LOQs ranged from 0.035 μg kg-1 to 16.0 485 
μg kg-1 (Table 2). 486 
 487 
3.3.3. Matrix effects 488 
During the matrix effect study, ion suppression was observed for the majority of the analytes, 489 
while biapenem, cefoperazone, cefquinome, imipenem and methicillin showed ion 490 
enhancement. The greatest amount of ion suppression and enhancement was observed for 491 
amoxicillin and methicillin, respectively (75% and 73%). The use of the 10 internal standards 492 
significantly improved the precision of the method (Table 2 and Table 3) and represented a 493 
distinguishing feature of the proposed work. With the exception of Berendsen et al. [2], none 494 
of the previously published methods included such a large number of deuterated standards. 495 
However, the available labelled compounds were found not suitable in the quantification of 496 
biapenem, cefoperazone, cefquinome, DCD, imipenem, meropenem, methicillin, piperacillin 497 
and ticarcillin. Among the analytes corrected using a labelled compound, mecillinam showed 498 
the greatest variability (RSD% = 26.2%). It is highlighted that no MRL is required for 499 
mecillinam in bovine species. Cefquinome was the only MRL-substance that showed ion 500 
enhancement. The use of an internal standard is particularly important for those analytes for 501 
which ion enhancement is observed. In the event of positive samples being found, this matrix 502 
effect can potentially lead, indeed, to false non-compliant results. However, in the proposed 503 
method, the available labelled compounds were found to be unsuitable for the quantification 504 
of cefquinome. In addition, the matrix effect study showed a variability of 28.9%. This 505 
problem should be addressed in the future through the implementation of a suitable 506 
isotopically labelled standard. 507 
 508 
3.3.4. Trueness, precision, absolute recovery, CCα and CCβ 509 
The 2002/657/EC guidelines specify that the trueness for mass fractions between 1 and 10 µg 510 
kg-1 should be in the range 70-110%, while the trueness for mass fractions ≥ 10 µg kg-1 511 
should be in the range 80-110%. The trueness was satisfactory for all the analytes under WLr 512 
conditions (range of 86-108%). On day two of the WLR study, the mixed internal standard 513 
solution was accidentally added twice to one of the samples fortified at 1.5 MRL/TL, while 514 
the internal standard was not added to the following sample. Consequently, six replicates 515 
were used on that day for the assessment of WLR at 1.5 MRL/TL for those analytes corrected 516 
using an internal standard. The trueness was satisfactory for the majority of substances under 517 
WLR conditions (range of 81-108%). The exceptions were mecillinam (69% accuracy at TL), 518 
meropenem (115-125%) and faropenem (119-143%). For mecillinam and faropenem, the 519 
trueness was outside the acceptable range even though the internal standards cefazolin-520 
13C2
15N and ampicillin-D5 were used, respectively. In the case of meropenem, for which no 521 
internal standards were used, the corresponding labelled compound, namely meropenem-D6, 522 
could be implemented into the method to address the problem. The 2002/657/EC guidelines 523 
also state that the coefficient of variations (CVs) for mass fractions between 100 and 1000 µg 524 
kg-1 shall be ≤ 23% in WLR conditions. For mass fractions lower than 100 µg kg-1, the CVs 525 
shall be as low as possible. In addition, the CVs calculated under WLr conditions should not 526 
be greater than two thirds of the CVs calculated under WLR conditions. The precision of the 527 
method was satisfactory for all analytes in both WLR (2.0-29.9%) and WLr studies (1.5-528 
17.3%), as the CVs did not exceed the maximum CVs calculated by the Horwitz equation and 529 
two thirds of these values, respectively. 530 
CCα ranged from 10.6 µg kg-1 (cefazolin) to 677 µg kg-1 (DCD), depending on the analyte. 531 
Overall absolute recoveries (OAR) ranged from 61% to 89% for all the compounds, except 532 
for cefadroxil, DCCD, DCD, imipenem and ertapenem (Table 3). Cefadroxil, ertapenem and 533 
imipenem are relatively polar analytes, and the lower recovery rates were probably due to the 534 
incomplete extraction from the matrix, caused by the specific extraction solvent composition 535 
used in the sample preparation. In the case of DCCD and DCD, the disulphide bonds present 536 
in their molecular structures likely undergo exchange with protein thiols or other disulphide 537 
bonds in the homogenised tissue samples, resulting in losses during the deproteinization step 538 
or in the non-detection by the LC-MS/MS system [17]. It is important to state that all active 539 
metabolites should be included in the analysis of ceftiofur residues in food products, as the 540 
MRL for muscle tissue in all mammalian food-producing species is defined as the sum of all 541 
residues retaining the β-lactam structure, expressed as desforylceftiofur [7]. After 542 
intramuscular administration, ceftiofur is rapidly metabolised to desfuroylceftiofur and 543 
further products, including protein-bound desfuroylceftiofur [26]. Since no hydrolysis is 544 
involved, the method described in this study does not detect protein-bound metabolites, 545 
consequently it leads to an underestimation of the total ceftiofur content. To measure the total 546 
amount of ceftiofur present in a sample, all the disulphide bonds should be reduced and 547 
desfuroylceftiofur released, followed by stabilisation of the thiol group by derivatization [22, 548 
26]. 549 
 550 
Cephapirin could not be directly included in the proposed method. A very rapid conversion of 551 
cephapirin to its active metabolite (DAC) in milk, kidney homogenate and fortified muscle 552 
tissue samples was reported in literature [16, 41, 55, 56]. The preliminary experiments 553 
performed during the development of the proposed method employed the use of mixes 554 
containing both cephapirin and DAC and showed no absolute recovery for cephapirin and 555 
180-190% absolute recovery for DAC. For this reason, a quantitative conversion of 556 
cephapirin to DAC was hypothesised after fortification of blank muscle tissue homogenate 557 
samples (in approximately 15 min), resulting in the impossibility to quantify cephapirin 558 
directly. However, as highlighted by Fagerquist and Lightfield (2003), if this compound was 559 
present in a real sample, it would be rapidly and completely converted to DAC after a 560 
preliminary homogenisation aimed to obtain a representative sample [16]. 561 
 562 
Although no MRLs are required for cefacetrile, cefalonium, cefazolin, cefoperazone, 563 
mecillinam and penicillin V in bovine muscle, the inclusion of these drugs in the proposed 564 
method could provide useful information on their transmission through the food chain in the 565 
case that positive samples are found. In addition, as a MRL is required for penicillin V in 566 
liver, kidney, skin and fat, and for cefacetrile, cefalonium, cefazolin and cefoperazone in 567 
milk, the sample preparation could be adapted to different matrices, while using the same 568 
UHPLC-MS/MS method. 569 
 570 
 571 
4. Comparison with other existing methods 572 
Relatively few multi-residue LC-MS methods have been published for the analysis of β-573 
lactams in muscle tissue. A preliminary literature review found few methods dealing with 574 
penicillins and cephalosporins [19-21, 25, 27-40]. Most of these methods include few 575 
analytes or exclude cephapirin and ceftiofur metabolites. On the other hand, other methods 576 
describe dedicated tests for ceftiofur and its metabolites only [23, 26]. With the exception of 577 
Berendsen et al. [2], no methods have been reported at all for carbapenems in food products. 578 
Although the Berendsen method represents the most valid approach for monitoring ceftiofur 579 
and the total amount of its metabolites, it involves a complex derivatisation process followed 580 
by SPE clean-up. A time consuming sample preparation including SPE clean-up is also 581 
involved in the method reported by Becker et al. [41] (Fig. 7). The method described in this 582 
study consists of a fast and easy sample preparation protocol and allows the simultaneous 583 
analysis of 30 β-lactam antibiotics, including carbapenems, DAC and two of the ceftiofur 584 
metabolites, in a reasonably short chromatographic run (18 min). The method published by 585 
Geis-Asteggiante et al. (2012) had previously applied the same sample preparation to bovine 586 
muscle for the analysis of several veterinary drug residues belonging to different classes of 587 
antibiotics [50]. It has to be said that the development of a multi-residue method is 588 
particularly difficult when several analytes with a wide range of chemical properties are 589 
present. However, for the 10 β-lactams included in the Geis-Asteggiante method, the average 590 
reproducibility %CV ranged from 8.0% to 49.0%, while the reproducibility of the proposed 591 
method could be improved by using 10 different internal standards and ranged between 2.0% 592 
and 29.9%. Finally, limits of quantitation for the MRL-substances were well below half the 593 
MRLs set by current legislation [7]. 594 
 595 
 596 
5. Conclusions 597 
This research has demonstrated that it is possible to accurately measure 30 β-lactam residues 598 
belonging to the penicillin, cephalosporin and carbapenem families in bovine muscle samples 599 
by UHPLC-MS/MS following a generic sample preparation protocol. A range of different 600 
clean-up procedures were evaluated during method development, and d-SPE with C18 was 601 
found to give the best overall recoveries. The performance of the method was assessed during 602 
matrix effects studies and validation studies, showing it was necessary to include isotopically 603 
labelled internal standards to improve accuracy. It was shown in this work that β-lactam 604 
residues are particularly unstable and protocols need to be implemented in test methods to 605 
mitigate against this problem. Firstly, this work demonstrated that MeOH should not be 606 
employed for the preparation of standards, as it causes degradation of some penicillins. This 607 
can potentially lead to the identification and selection of incorrect precursor/product ions, as 608 
well as an overestimation of beta-lactam residue levels in test samples. This standard stability 609 
problem can be addressed through the use of alternative solvents, such as H2O/MeCN and 610 
DMSO. Additionally, it is recommended that MeOH should not be used during sample 611 
preparation or during UHPLC-MS/MS analysis. This research concurs with previous research 612 
findings that proposed that temperature needs to be carefully controlled during β-lactam 613 
analysis. Our study found that analyte recovery and method precision can be improved by 614 
extraction over ice, maintaining evaporation at 40°C and reducing chromatographic column 615 
temperature to 30°C. 616 
The final method is advantageous over previous methods because it includes the widest range 617 
of β-lactams and allows the analysis of carbapenem residues without the need for 618 
derivatisation. The method has a reasonably high throughput that allows one analyst working 619 
alone to analyse 30 test samples along with calibration and quality control samples in one 620 
day. The method was validated according to the 2002/657/EC guidelines and was 621 
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Imipenem [M+H]+ 2.28 300.1 142.0a/126.1 0.194 22 28/17 1 
Biapenem [M+H]+ 2.81 351.2 110.2a/170.1 0.180 25 19/20 2 
Amoxicillin [M+H]+ 3.21 366.1 114.0a/349.1 0.035 18 20/9 3 
Amoxicillin-D4 [M+H]+ 3.21 370.6 354.0 0.020 16 9 3 
Cefadroxil [M+H]+ 3.24 364.1 208.1a/158.0 0.030 15 9/9 3 
Cefadroxil-D4 [M+H]+ 3.23 368.6 115.0 0.012 16 20 3 
DAC [M+H]+ 3.28 382.1 152.1a/226.1 0.030 29 24/23 3 
DAC-D6 [M+H]+ 3.27 387.9 115.1 0.015 31 45 3 
Doripenem [M+H]+ 3.35 421.1 342.2a/274.2 0.021 20 13/16 3 
Meropenem [M+H]+ 3.50 384.1 141.0a/114.1 0.103 23 15/23 4 
Ampicillin [M+H]+ 3.75 350.1 106.1a/192.1 0.033 22 21/16 5 
Ampicillin-D5 [M+H]+ 3.74 355.0 197.1 0.025 18 16 5 
Cephalexin [M+H]+ 3.74 348.1 158.1a/174.1 0.036 20 9/17 5 
Cephalexin-D5 [M+H]+ 3.73 353.0 179.1 0.025 17 14 5 
Cephapirin [M+H]+ 3.76 424.0 292.1a/152.1 0.040 24 15/24 5 
Cefquinome [M+H]+ 4.05 529.0 134.2a/167.1 0.074 21 13/23 6 
Ertapenem [M+H]+ 4.19 476.1 432.1a/233.2 0.016 20 9/14 6 
Mecillinam [M+H]+ 4.19 326.1 167.2a/139.2 0.022 34 15/29 6 
DCCD [M+H]+ 4.26 548.7 183.1a/241.2 0.032 36 29/20 6 
DCCD-D3 [M+H]+ 4.26 551.9 366.0 0.032 36 21 6 
Cefalonium [M+H]+ 4.24 458.9 152.0a/337.0 0.006 18 18/10 6 
Cefacetrile [M+NH4]+ 4.92 357.0 280.1a/252.1 0.056 16 9/14 7 
Cefotaxime [M+H]+ 4.92 456.1 396.0a/167.1 0.080 23 10/19 7 
Faropenem [M+Na]+ 5.04 308.0 178.0a/222.1 0.047 26 18/12 8 
Cefazolin [M+H]+ 5.13 454.9 156.0a/295.1 0.047 17 15/15 8 
Cefazolin-13C215N [M+H]+ 5.13 457.8 298.1 0.047 15 16 8 
Cefuroxime [M+NH4]+ 5.39 442.0 364.1a/336.1 0.129 16 14/14 9 
Cefoperazone [M+H]+ 5.57 646.0 143.2a/530.0 0.022 25 33/12 10 
DCD [M+2H]2+ 5.71 429.2 183.1a/397.0 0.026 23 21/13 10 
Ticarcillin [M+H]+ 5.82 385.1 160.1a/114.1 0.039 25 14/36 10 
Methicillin [M+H]+ 5.98 381.1 165.2a/222.2 0.038 27 23/18 10 
Piperacillin [M+H]+ 6.02 518.0 143.2a/160.1 0.020 28 17/10 10 
Penicillin G [M+H]+ 6.23 335.1 160.1a/176.1 0.135 21 12/12 11 
Penicillin G-D7 [M+H]+ 6.21 342.0 183.1 0.080 18 11 11 
Penicillin V [M+H]+ 6.54 351.1 160.1a/114.1 0.139 21 13/33 12 
Penicillin V-D5 [M+H]+ 6.52 355.9 160.0 0.050 20 15 12 
Oxacillin [M+H]+ 6.76 402.1 160.1a/243.2 0.150 20 16/14 13 
Cloxacillin [M+H]+ 7.04 436.0 160.1a/277.1 0.115 22 12/12 14 
Nafcillin [M+H]+ 7.16 415.1 199.2a/171.2 0.081 20 7/28 14 
Nafcillin-D5 [M+H]+ 7.15 420.0 261.1 0.050 19 17 14 
Dicloxacillin [M+H]+ 7.41 470.0 160.2a/114.2 0.151 22 14/34 15 
a = Quantitation ion; RT = Retention Time; CV = Cone Voltage; CE = Collision Energy. 
b = MRM Windows: 1 = (1.99 – 2.98 min); 2 = (2.60 - 3.13 min); 3 = (2.98 – 3.50 min); 4= (3.41 – 3.62 min); 5 = (3.60 – 3.88 min); 
6 = (3.91 – 4.42 min); 7 = (4.75 – 5.10 min); 8 = (4.93 – 5.26 min); 9 = (5.23 – 5.57 min); 10 = (5.35 – 6.27 min); 11 = (6.05 – 6.36 
min); 12 = (6.36 – 6.69 min); 13 = (6.62 – 6.99 min); 14 = (6.82 – 7.35 min); 15 = (7.23 – 7.58 min). 
Table 2. Calibration ranges, LODs, LOQs and matrix effect data. Positive values indicate ion 
















Amoxicillin 12.5-100 0.994 0.50 1.7 75 17.2 4.6 
Ampicillin 12.5-100 0.994 0.050 0.17 34.1 12.2 3.2 
Cloxacillin 75-600 0.998 0.15 0.50 13.8 4.7 4.5 
Dicloxacillin 75-600 0.998 0.10 0.30 10.6 6.7 5.5 
Mecillinam 2.5-20 0.996 0.030 0.10 19.7 27.0 26.2 
Methicillin 2.5-20 0.994 0.030 0.10 -73 19.6 No IS used 
Nafcillin 75-600 0.998 0.030 0.10 9.5 4.2 1.6 
Oxacillin 75-600 0.992 0.010 0.035 17.0 5.4 4.9 
Penicillin G 12.5-100 0.993 0.040 0.12 19.2 7.2 4.1 
Penicillin V 6.25-50 0.998 0.020 0.070 14.3 3.6 3.7 
Piperacillin 2.5-20 0.997 0.040 0.12 5.8 9.3 No IS used 
Ticarcillin 5-40 0.993 0.30 1.0 21.7 10.0 No IS used 
Cefacetrile 5-40 0.994 0.30 1.0 44.6 22.7 12.5 
Cefadroxil 12.5-100 0.988 1.3 4.2 69 22.0 11.0 
Cephalexin 50-400 0.998 0.50 1.7 23.7 10.9 3.2 
Cefalonium 5-40 0.989 0.30 1.0 42.0 20.2 13.9 
Cefazolin 2.5-20 0.997 0.10 0.30 35.8 13.8 3.7 
Cefoperazone 5-40 0.994 0.30 1.0 -15.2 9.2 No IS used 
Cefotaxime 5-40 0.994 0.30 1.0 43.3 24.6 14.1 
Cefquinome 12.5-100 0.989 0.070 0.22 -34.1 28.9 No IS used 
Cefuroxime 5-40 0.995 0.30 1.0 6.8 7.8 7.7 
DAC 12.5-100 0.995 0.60 1.9 70 23.6 5.8 
DCCD 125-1000 0.993 4.8 16.0 44.1 14.3 4.6 
DCD 125-1000 0.990 0.20 0.70 52 10.1 No IS used 
Biapenem 5-40 0.992 0.30 1.0 -34.8 19.5 No IS used 
Doripenem 12.5-100 0.991 1.0 3.0 42.9 25.0 21.6 
Ertapenem 50-400 0.994 1.5 5.0 30.5 8.6 8.7 
Imipenem 12.5-100 0.994 0.50 1.7 -45.8 15.2 No IS used 
Meropenem 5-40 0.997 0.30 1.0 61 12.3 No IS used 
Faropenem 12.5-100 0.995 0.50 1.7 48.1 35.8 25.0 
a = Results are based on the analysis of 27 different bovine muscle samples; IS = Internal Standard. 





















Amoxicillin 50 102 (5.9) 101 (4.5) 103 (5.2) 101 (6.4) 101 (5.4) 101 (5.8) 55 60 69 (2.4) 70 (5.5) 
Ampicillin 50 101 (2.4) 99 (2.4) 101 (3.3) 100 (4.3) 102 (3.6) 100 (4.0) 54 58 78 (7.9) 76 (4.8) 
Cloxacillin 300 103 (2.2) 101 (2.2) 101 (1.7) 102 (6.0) 99 (5.2) 95 (7.5) 350 399 81 (5.6) 88 (3.6) 
Dicloxacillin 300 104 (2.4) 103 (2.3) 104 (5.0) 102 (6.2) 99 (3.7) 97 (5.6) 321 351 83 (2.3) 87 (3.4) 
Mecillinam 10 96 (2.5) 97 (3.3) 100 (4.0) 81 (29.0) 69 (29.9) 91 (21.6) 13.1 19.6 85 (1.1) 83 (2.5) 
Methicillin 10 108 (10.2) 104 (9.5) 98 (6.7) 91 (13.2) 90 (14.8) 91 (13.0) 12.2 15.8 85 (5.0) 84 (4.4) 
Nafcillin 300 101 (2.2) 101 (1.8) 100 (1.5) 104 (6.2) 101 (3.2) 99 (4.2) 326 350 84 (2.0) 88 (4.2) 
Oxacillin 300 103 (2.7) 101 (3.2) 101 (3.2) 105 (6.4) 103 (3.6) 101 (4.3) 322 347 78 (12.6) 89 (5.8) 
Penicillin G 50 106 (2.8) 105 (2.8) 105 (2.4) 100 (6.7) 104 (12.6) 103 (14.9) 62 84 79 (12.5) 85 (3.1) 
Penicillin V 25 101 (2.4) 100 (2.3) 102 (2.8) 98 (4.8) 98 (2.3) 100 (2.8) 26.0 27.3 87 (1.5) 86 (3.4) 
Piperacillin 10 104 (4.9) 104 (5.8) 105 (5.3) 102 (7.4) 102 (6.1) 102 (5.3) 11.5 12.6 89 (4.0) 85 (4.6) 
Ticarcillin 20 99 (6.4) 99 (8.6) 100 (6.7) 99 (10.0) 105 (10.3) 95 (8.9) 28.5 34.1 61 (5.3) 62 (6.6) 
Cefacetrile 20 101 (4.3) 100 (4.6) 99 (8.2) 108 (9.6) 104 (5.5) 101 (8.9) 22.9 27.1 80 (2.7) 79 (3.4) 
Cefadroxil 50 100 (5.7) 98 (5.4) 101 (6.3) 101 (10.9) 98 (5.6) 97 (6.7) 54 60 58 (2.1) 61 (8.1) 
Cephalexin 200 98 (1.9) 98 (1.9) 100 (3.5) 101 (3.5) 100 (2.0) 99 (3.6) 202 213 69 (4.8) 67 (3.9) 
Cefalonium 20 100 (8.9) 100 (5.6) 100 (6.0) 99 (12.6) 98 (8.0) 101 (8.5) 21.9 25.0 79 (13.0) 81 (2.4) 
Cefazolin 10 101 (5.0) 101 (4.5) 100 (5.2) 98 (6.8) 101 (5.6)  101 (8.3) 10.6 11.9 81 (4.6) 83 (4.2) 
Cefoperazone 20 104 (5.5) 101 (7.0) 102 (6.3) 101 (6.7) 100 (8.5) 101 (8.0) 23.7 27.4 86 (3.7) 86 (6.7) 
Cefotaxime 20 102 (6.4) 104 (5.2) 101 (6.5) 101 (6.6) 104 (6.1) 107 (8.8) 21.9 25.0 64 (5.0) 67 (7.0) 
Cefquinome 50 103 (7.0) 101 (11.5) 100 (6.9) 95 (10.5) 96 (12.7) 91 (7.1) 68 79 87 (3.5) 86 (5.3) 
Cefuroxime 20 104 (7.2) 102 (6.7) 101 (7.2) 100 (7.2) 105 (6.7) 104 (10.7) 21.1 24.7 87 (1.4) 84 (3.2) 
DAC 50 102 (4.9) 101 (4.4) 101 (3.7) 99 (6.8) 97 (5.2) 99 (4.1) 53 57 77 (5.0) 78 (2.7) 
DCCD 500a 104 (4.8) 101 (5.9) 104 (4.7) 101 (4.8) 99 (5.9) 99 (4.7) 536 584 40.3 (7.8) 45.1 (2.9) 
DCD 500a 108 (5.2) 102 (7.0) 103 (8.8) 99 (9.7) 106 (9.4) 98 (8.8) 677 802 53 (4.7) 56 (7.9) 
Biapenem 20 106 (5.6) 103 (2.9) 103 (5.8) 91 (14.2) 84 (13.9) 92 (8.2) 23.0 27.3 71 (2.2) 71 (3.6) 
Doripenem 50 106 (4.8) 103 (7.1) 100 (4.7) 96 (10.9) 94 (8.8) 96 (12.3) 57 71 62 (3.9) 65 (2.8) 
Ertapenem 200 101 (4.7) 97 (4.3) 102 (8.0) 96 (9.0) 95 (7.3) 100 (8.4) 213 242 44.2 (6.4) 43.3 (6.8) 
Imipenem 50 106 (6.0) 100 (8.4) 86 (10.9) 96 (10.9) 102 (10.2) 86 (13.9) 69 90 47.0 (8.3) 51 (4.9) 





















Meropenem 20 104 (3.6) 100 (6.0) 99 (3.6) 115 (21.5) 125 (23.4) 122 (22.4) 28.4 44.1 66 (0.46) 66 (8.4) 
Faropenem 50 97 (17.3) 96 (14.8) 97 (11.7) 128 (17.8) 143 (14.9) 119 (13.5) 77 100 78 (0.10) 79 (3.3) 
TL = Target Level; OAR = Overall Absolute Recovery; LCL = Lowest Calibration Level; HCL = Highest Calibration Level.  
a = Validation levels were 250, 500 and 750 µg kg-1 (MRL established by (EU) 37/2010 is 1000 µg kg-1 for the sum of all residues retaining the β-lactam structure,  






Penicillin R Penicillin R 
Amoxicillin -C7H8NO Oxacillin -C10H8NO 
Ampicillin -C7H8N Penicillin G -C7H7 
Cloxacillin -C10H7ClNO Penicillin V -C7H7O 
Dicloxacillin -C10H6Cl2NO Piperacillin -C14H16N3O3 
Methicillin -C8H9O2 Ticarcillin -C6H5O2S 






Cephalosporin R1 R2 Cephalosporin R1 R2 
Cefacetrile -C3H5O2 -C2H2N Cefotaxime -C3H5O2 -C5H6N3OS 
Cefadroxil -CH3 -C7H8NO Cefquinome -C10H13N -C5H6N3OS 
Cephalexin -CH3 -C7H8N Cefuroxime -C2H4NO2 -C6H6NO2 
Cefalonium -C7H8N2O -C5H5S DAC -CH3O -C6H6NS 
Cefazolin -C4H5N2S2 -C2H3N4 DCD -CH2S -C5H6N3OS 
Cefoperazone -C3H5N4S -C14H16N3O4 DCCD -C4H8NO2S2 -C5H6N3OS 
 




Carbapenem R1 R2 
Biapenem -CH3 -C5H7N3S 
Doripenem -CH3 -C5H12N3O2S2 
Ertapenem -CH3 -C12H13N2O3S 
Imipenem -H -C3H7N2S 
Meropenem -CH3 -C7H13N2OS 
 































Fig. 2. Overlay of LC-MS/MS chromatograms for the β-lactams (A-C) and internal standards (D-E) 



















































Fig. 3. Average recoveries (and standard deviations, shown by error bars) obtained using NH2, PSA, Z-Sep and C8 sorbents or hexane liquid-liquid 





































Fig. 5. MS spectra obtained from a cloxacillin standard solution prepared in H2O:MeCN (A) and a 





































































Fig. 6. Extracted chromatograms for the masses 436.0 m/z (A) and 468.0 m/z (B) obtained after 
column injections of 10 µg mL-1 cloxacillin standard solutions prepared in H2O:MeCN or MeOH 
and stored for 11 days at different temperatures.  RT = Room Temperature. 
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Fig. 7. Flow diagram of published methods (Becker et al. (2004) [41]; Berendsen et al. (2013) [2]) 
sample preparation procedures and comparison with the proposed method for the extraction of β-
lactam residues from muscle tissue samples, showing steps and time required. The estimated time 
for each step is based on the extraction of one sample only. 
